BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
PRODID:-//Telerik Inc.//Sitefinity CMS 15.4//EN
BEGIN:VTIMEZONE
TZID:Central Standard Time
BEGIN:STANDARD
DTSTART:20251102T020000
RRULE:FREQ=YEARLY;BYDAY=1SU;BYHOUR=2;BYMINUTE=0;BYMONTH=11
TZNAME:Central Standard Time
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:20250301T020000
RRULE:FREQ=YEARLY;BYDAY=2SU;BYHOUR=2;BYMINUTE=0;BYMONTH=3
TZNAME:Central Daylight Time
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DESCRIPTION:Thursday\, December 4\, 202512:00pm - 1:00pmHybrid Attendance: 
 Research Bldg. 6\, 1.206 Auditoriumor Zoomhttps://www.zoomgov.com/s/160903
 9203?pwd=ZGILbiLGtdLuMnWgX9TrdHhw06tyb2.1passcode: 089555&nbsp\;"Practical
  Primary-Care Approach to COPD: Diagnosis\, Treatment\, and Monitoring"Gue
 st PresenterDr. Barbara P. Yawn\, MD\, MSc\, FAAFPAdjunct Professor\, Univ
 ersity of MinnesotaFamily and Community HealthKey Objectives:Identify late
 st recommendations for COPD care.Apply recommendations to real world prima
 ry care to improve patient outcomes.Know how to incorporate validated tool
 s to enhance primary care management of COPD.Determine when to use referra
 l and consultation in COPD care.&nbsp\;Target Audience and Needs: Internal
  Medicine faculty\, staff\, registered nurses\, residents\, fellows\, stud
 ents\, and internists specializing in Allergy &amp\; Immunology\, Cardiolo
 gy\, Endocrinology\, Gastroenterology\, General Medicine\,\n    Geriatrics
 \, Hematology &amp\; Oncology\, Infectious Diseases\, Nephrology\, Palliat
 ive Care\, Pulmonary Critical Care &amp\; Sleep Medicine\, and Rheumatolog
 y need to be regularly updated with new research and guidelines regarding 
 the evaluation\n    and management of medical disorders and implement them
  in clinical practice to enhance the quality of patient care and improve p
 atient outcomes.Educational Methods: Educational methods will include lect
 ures\, case presentations\, literature review\, and panel discussion.Activ
 ity Evaluation: Participants may be asked to complete a session evaluation
 .Financial Disclosure: The following are reports of relationships with com
 mercial interests by those individuals who are in the position to control 
 the content of this activity.Dr. Barbara Yawn\, MD. The speaker discloses 
 the following commercial interests: NHLBI\, PCORI (Research funding): Astr
 aZeneca\, Behringer Ingelheim (Consultant\, Advisory Board): Glaxo Smith K
 line (Consultant\, Advisory Board\, Speaker): Teva\, Modema (Consultant)\;
  MedScape\, Merck (Advisory Board). Any potential conflicts for this prese
 ntation have been resolved and the speaker attests that the clinical recom
 mendations within this presentation are evidence-based and free of commerc
 ial bias (e.g.. peer-reviewed literature\, adhering to evidence-based prac
 tice guidelines).Accreditation/Credit Designation: The University of Texas
  Medical Branch is accredited by the Accreditation Council for Continuing 
 Medical Education (ACCME) to provide continuing medical education for phys
 icians.The University of Texas Medical Branch designates this live activit
 y for a maximum of _1_ AMA PRA Category 1 Credits&trade\;. Physicians shou
 ld claim only the credit commensurate with the extent of their participati
 on in the activity.
DTEND:20251204T190000Z
DTSTAMP:20260713T091733Z
DTSTART:20251204T180000Z
LOCATION:
SEQUENCE:0
SUMMARY:Grand Rounds - 12/04/2025
UID:RFCALITEM639195130534779779
X-ALT-DESC;FMTTYPE=text/html:<p style="text-align:center\;"><strong>Thursda
 y\, December 4\, 2025</strong><br /><strong>12:00pm - 1:00pm</strong><br /
 ><br /><strong style="color:#da1f12\;">Hybrid Attendance: Research Bldg. 6
 \, 1.206 Auditorium<br />or </strong><br /><strong style="color:#da1f12\;"
 >Zoom</strong><strong><br /></strong></p><p style="text-align:center\;"><a
  href="https://www.zoomgov.com/s/1609039203?pwd=ZGILbiLGtdLuMnWgX9TrdHhw06
 tyb2.1">https://www.zoomgov.com/s/1609039203?pwd=ZGILbiLGtdLuMnWgX9TrdHhw0
 6tyb2.1</a></p><p style="text-align:center\;">passcode: 089555<strong></st
 rong></p><p style="text-align:center\;"><strong>&nbsp\;</strong></p><p sty
 le="text-align:center\;font-size:large\;"><strong>"Practical Primary-Care 
 Approach to COPD: Diagnosis\, Treatment\, and Monitoring"<br /></strong></
 p><p style="text-align:center\;"><strong>Guest Presenter</strong></p><p st
 yle="text-align:center\;font-size:large\;"><strong>Dr. Barbara P. Yawn\, M
 D\, MSc\, FAAFP</strong><br /><span style="font-size:medium\;">Adjunct Pro
 fessor\, University of Minnesota<br />Family and Community Health<br /><br
  /><br /></span></p><p style="text-align:left\;"><strong>Key Objectives:</
 strong></p><ol style="text-align:center\;"><li style="text-align:left\;">I
 dentify latest recommendations for COPD care.</li><li style="text-align:le
 ft\;">Apply recommendations to real world primary care to improve patient 
 outcomes.</li><li style="text-align:left\;">Know how to incorporate valida
 ted tools to enhance primary care management of COPD.</li><li style="text-
 align:left\;">Determine when to use referral and consultation in COPD care
 .</li></ol><p>&nbsp\;</p><p style="text-align:left\;"><strong>Target Audie
 nce and Needs: </strong>Internal Medicine faculty\, staff\, registered nur
 ses\, residents\, fellows\, students\, and internists specializing in Alle
 rgy &amp\; Immunology\, Cardiology\, Endocrinology\, Gastroenterology\, Ge
 neral Medicine\,\n    Geriatrics\, Hematology &amp\; Oncology\, Infectious
  Diseases\, Nephrology\, Palliative Care\, Pulmonary Critical Care &amp\; 
 Sleep Medicine\, and Rheumatology need to be regularly updated with new re
 search and guidelines regarding the evaluation\n    and management of medi
 cal disorders and implement them in clinical practice to enhance the quali
 ty of patient care and improve patient outcomes.</p><p style="text-align:l
 eft\;"><strong>Educational Methods: </strong>Educational methods will incl
 ude lectures\, case presentations\, literature review\, and panel discussi
 on.</p><p style="text-align:left\;"><strong>Activity Evaluation: </strong>
 Participants may be asked to complete a session evaluation.</p><p style="t
 ext-align:left\;"><strong>Financial Disclosure: </strong>The following are
  reports of relationships with commercial interests by those individuals w
 ho are in the position to control the content of this activity.</p><p styl
 e="text-align:left\;"><strong>Dr. Barbara Yawn\, MD. The speaker discloses
  the following commercial interests: NHLBI\, PCORI (Research funding): Ast
 raZeneca\, Behringer Ingelheim (Consultant\, Advisory Board): Glaxo Smith 
 Kline (Consultant\, Advisory Board\, Speaker): Teva\, Modema (Consultant)\
 ; MedScape\, Merck (Advisory Board). Any potential conflicts for this pres
 entation have been resolved and the speaker attests that the clinical reco
 mmendations within this presentation are evidence-based and free of commer
 cial bias (e.g.. peer-reviewed literature\, adhering to evidence-based pra
 ctice guidelines).<strong></strong></strong></p><strong><strong></strong><
 p style="text-align:left\;"><small>Accreditation/Credit Designation: </sma
 ll><small>The University of Texas Medical Branch is accredited by the Accr
 editation Council for Continuing Medical Education (ACCME) to provide cont
 inuing medical education for physicians.</small></p><small></small><p styl
 e="text-align:left\;"><small>The University of Texas Medical Branch design
 ates this live activity for a maximum of _1_ AMA PRA Category 1 Credits&tr
 ade\;. Physicians should claim only the credit commensurate with the exten
 t of their participation in the activity.</small></p><strong></strong></st
 rong>
END:VEVENT
END:VCALENDAR